U.S. Pharma Stock News

Donnelley Financial Solutions recently reported quarterly results that showed 10.4% year-on-year revenue growth and earnings and revenue exceeding analyst expectations, underlining its operational strength in compliance and regulatory software services. This outperformance, coupled with analysts revising earnings estimates upward and maintaining a top-tier Zacks Rank, highlights growing confidence in Donnelley Financial Solutions' ability to convert regulatory complexity into higher-quality...

If you are wondering whether Artisan Partners Asset Management is attractively priced at the moment, you are not alone. Many investors are asking the same question. The stock last closed at US$36.28, with returns of a 9.4% decline over 7 days, a 21.5% decline over 30 days, a 12.4% decline year to date, a 2.6% gain over 1 year, a 55.6% gain over 3 years, and a 3.5% gain over 5 years. Recent headlines around Artisan Partners Asset Management have focused on its role as an active asset manager...

Earnings snapshot and dividend update W&T Offshore (WTI) has drawn fresh attention after reporting fourth quarter and full year 2025 results, with lower annual revenue, a larger net loss, and a maintained quarterly dividend. See our latest analysis for W&T Offshore. The latest earnings release and the recent affirmation of the US$0.01 quarterly dividend came alongside a 67.65% 3 month share price return and a 94.69% 1 year total shareholder return. However, the 3 year total shareholder return...

Tilman Fertitta is in exclusive talks to acquire Caesars Entertainment, a core tenant of NYSE:VICI. The discussions focus on a potential company wide takeover of Caesars, which operates multiple casino and entertainment properties tied to VICI leases. The outcome could influence rental terms, property usage, and future capital plans across VICI owned real estate connected to Caesars. For you as an investor, this matters because VICI Properties is a major casino and experiential REIT, and...

Edwards Lifesciences (EW) has been back in focus after moving to sell its critical care unit and to concentrate on areas such as asymptomatic aortic stenosis and structural heart failure, along with fresh Q4 numbers. See our latest analysis for Edwards Lifesciences. The recent decision to sell the critical care unit, Q4 results, and the appointment of a new Director of Government Affairs have all come as Edwards Lifesciences posts a 10.79% 1 month share price return and a 24.20% 1 year total...

Wondering if Cogent Communications Holdings is now priced attractively or if the share price still does not reflect its fundamentals? This article walks through the key valuation angles to help you frame that question for yourself. The stock closed at US$21.34, with returns of a 7.6% decline over 7 days, a 14.9% decline over 30 days, a 3.5% gain year to date, and a 67.4% decline over 1 year, which naturally raises questions about how the market is reassessing its prospects and risks. Recent...

If you are wondering whether Oshkosh at around US$152 a share still offers value, or if most of the opportunity has already played out, this article walks you through what the current price really implies. The stock has seen a 15.3% gain year to date and a 62.0% return over the last year, even after an 8.7% pullback over the past week and an 11.7% decline across the last month. Recent attention on Oshkosh has focused on its position in capital goods and investor debate about how its order...

Why American Water Works Company (AWK) Is Back On Investors’ Radar Recent share price moves in American Water Works Company (AWK) have caught investor attention, with the stock up around 9% over the past month and roughly 3% over the past 3 months. That performance sits alongside reported revenue of about US$5.14b and net income of roughly US$1.11b, prompting some investors to revisit how this regulated water utility fits into a diversified portfolio. See our latest analysis for American...

If you are wondering whether Boston Scientific's current share price reflects its true worth, this article walks through what the numbers are actually saying about value. The stock last closed at US$69.63, with returns of a 3.6% decline over 7 days, a 6.1% decline over 30 days, a 26.5% decline year to date, and a 27.8% decline over the past year, set against gains of 45.2% over 3 years and 79.1% over 5 years. Recent coverage around Boston Scientific has focused on its position in the medical...

What Kimbell’s new buyback could mean for unitholders Kimbell Royalty Partners (KRP) has authorized a repurchase program for up to US$100 million of common units through 2027, giving management a new capital allocation lever alongside existing distributions. See our latest analysis for Kimbell Royalty Partners. The buyback news lands after a run of positive updates, including 2025 results, fresh 2026 production guidance and a higher cash distribution. The current US$14.62 unit price sits...

Why First Horizon is on investors’ radar today First Horizon (FHN) has been drawing attention after recent share price moves, with the stock showing a 1 day return of about a 1.7% decline and a month return near a 13.2% decline. Those short term pressures sit alongside a past 3 months return of roughly a 5.7% decline and a year total return of about 24.2%, giving investors a mixed snapshot of recent versus longer term performance. See our latest analysis for First Horizon. The recent share...

Emerson Electric (NYSE:EMR) leaders are scheduled to present at the 2026 J.P. Morgan Industrials Conference. The Chief Operating Officer and Chief Financial Officer are expected to speak at this high profile event. The conference appearance offers fresh insight into Emerson Electric’s priorities, capital allocation, and operational focus. For investors watching industrial automation, process control, and related software markets, Emerson Electric sits at the center of many long run spending...

Wondering if Toast at around US$28.70 is priced fairly or if the market is overlooking something? This article walks through what the current share price might be implying about the company. The stock is roughly flat over the last month with a 0.2% return, but that sits against a year to date decline of 15.6% and a 1 year decline of 17.5%. The 3 year return stands at 67.0%. Recent commentary around Toast has focused on its role in restaurant tech, how it is positioning its platform, and how...

What Is Happening With NMI Holdings Stock? NMI Holdings (NMIH) has been on investors' radar after recent price moves, with the shares closing at US$37.04 and showing mixed returns over the past year and the past 3 months. See our latest analysis for NMI Holdings. The recent share price weakness, with a 1-day share price return showing a 2.37% decline and a 30-day share price return showing a 7.26% decline from US$37.04, contrasts with a 1-year total shareholder return of 7.18% and a 3-year...

If you are looking at Portland General Electric and wondering whether US$52.11 per share is a fair price, you are not alone. The key question is how that price stacks up against the value of the business. The stock has seen mixed short term moves, with a 3.8% decline over the past week, a 3.0% gain over the last 30 days, and returns of 7.5% year to date and 25.4% over the past year, which can change how investors think about both upside and risk. Recent news around Portland General Electric...

ReNew Energy Global (NasdaqGS:RNW) just closed the sale of its GTL transmission project for about US$40 million, generating roughly US$16 million in net cash, a material liquidity boost directly supporting its renewable build out plans. See our latest analysis for ReNew Energy Global. ReNew Energy Global’s latest US$40 million GTL sale and recent board refresh come against a weak backdrop, with the share price down about 30% over 90 days and the 1-year total shareholder return at a 14.4%...

Mineralys Therapeutics recently reported that the FDA accepted its New Drug Application for lorundrostat for adults with hypertension, setting a PDUFA target action date of December 22, 2026, based on multiple trials showing blood pressure reductions and a favorable safety profile. Although the Phase 2 Explore-OSA study did not improve sleep apnea severity, its blood pressure benefit in a difficult-to-treat, obese hypertensive population highlights lorundrostat’s potential relevance across...

If you are wondering whether Open Text's share price still reflects its underlying business, you are not alone. This article looks at what the numbers say about value rather than headlines. At a last close of US$23.99, the stock has seen returns of a 4.3% decline over 7 days, a 5.4% decline over 30 days, a 24.4% decline year to date and a 1.6% decline over the past year, with a 25.5% decline over 3 years and a 43.3% decline over 5 years. Recent trading has been shaped by ongoing investor...

Amcor (NYSE:AMCR) is back in focus after its North American unit issued US$1.5b in senior unsecured guaranteed notes to refinance near term debt, following a recent 4.38% intraday share price drop. See our latest analysis for Amcor. That refinancing move comes after a choppy stretch, with a 7 day share price return of 7.37% and a 30 day share price return of 12.21%. However, the 1 year total shareholder return of 9.32% signals weak longer term momentum. If this kind of debt focused news has...

Ally Financial (ALLY) has rolled out an AI pilot for collections calls, drawing fresh attention to how this Detroit based digital bank is using automation to reshape operations in a tougher auto finance market. See our latest analysis for Ally Financial. Despite the AI rollout and recent conference commentary, Ally Financial’s 1 day share price return of a 1.42% decline and 7 day share price return of an 8.81% decline show pressure building in the short term, while its 1 year total...

If you are wondering whether Atmos Energy's share price still reflects fair value or if the market is getting ahead of itself, you are not alone. The stock last closed at US$184.30, with returns of 7.5% over 30 days, 8.8% year to date, 28.0% over 1 year, 74.4% over 3 years and 125.9% over 5 years. This recent performance is likely influencing how investors think about risk and upside. Recent evergreen coverage has focused on Atmos Energy's role as a regulated gas utility and how investors...

Babcock & Wilcox Enterprises (BW) just paired a profitable fourth quarter with a newly amended credit agreement, combining improved earnings with added borrowing capacity and extended debt maturities that could matter for investors watching its turnaround story. See our latest analysis for Babcock & Wilcox Enterprises. The turnaround signs appear to have caught the market’s attention, with a 1-day share price return of 5.13% and a 90-day share price return of 137.30% feeding into a very large...

Duolingo (DUOL) is back in focus after management told investors it will prioritize user growth, upgrade its free tier and aim to double daily active users by 2028, even if near term earnings take a hit. See our latest analysis for Duolingo. The recent focus on user growth comes after a sharp reset in sentiment, with Duolingo’s 1 day share price return of 3.81% and 7 day return of 2.75% sitting against a 30 day share price return decline of 16.90% and a year to date share price return decline...

Carter's, Inc. recently reported past fourth-quarter and full-year 2025 results showing higher quarterly sales and earnings year-on-year, issued 2026 net sales growth guidance, affirmed a US$0.25 quarterly dividend, and confirmed completion of a US$97.57 million buyback program initiated in 2022. Despite no share repurchases in fiscal 2025 and a sharp year-on-year drop in full-year net income to US$91.8 million, management’s guidance for net sales growth and continued dividend payments...